RAG-BioQA: Biomedical Retrieval-Augmented Generation

• RAG-BioQA is a retrieval-augmented generation paradigm that fuses dense retrieval and fine-tuned LLMs for evidence-based biomedical question answering.
• It employs multi-stage pipelines with iterative retrieval, reranking, and self-evaluation to improve answer precision and mitigate hallucinations.
• The framework leverages diverse biomedical sources and advanced strategies like MeSH filtering and hybrid retrieval to handle factoid, list, yes/no, and long-form questions.

RAG-BioQA designates retrieval-augmented generation for biomedical question answering: systems that retrieve biomedical evidence and condition a generator on that evidence to answer factoid, list, yes/no, summary, or long-form questions. In the recent literature, the label is used both for biomedical QA pipelines broadly and for specific instantiations, including BioRAG and the long-form framework titled “RAG-BioQA,” while closely related systems on BioASQ, PubMedQA, MedHopQA, and multimodal biomedical QA have expanded the design space of retrievers, rerankers, generators, and evaluators (Wang et al., 2024, Panchumarthi et al., 2 Oct 2025, Verma et al., 8 Jul 2025).

1. Problem setting and scope

Biomedical question answering is motivated by the scale, velocity, and heterogeneity of biomedical literature. Biomedical semantic question answering rooted in information retrieval has been described as crucial for keeping up to date with “vast, rapidly evolving and ever-growing biomedical literature,” and medical QA remains difficult for LLMs because of hallucinations and outdated domain knowledge (Verma et al., 8 Jul 2025, Dong et al., 30 Apr 2025). Long-form settings add a further constraint: systems must produce comprehensive explanations rather than only short-form labels, a gap explicitly identified by the PubMedQA-oriented “RAG-BioQA” framework (Panchumarthi et al., 2 Oct 2025).

The task space is correspondingly broad. BioASQ evaluates retrieval and answer generation for yes/no, factoid, list, and ideal answers; PubMedQA uses yes/no/maybe questions on PubMed abstracts; MedHopQA emphasizes multi-hop reasoning; MRAG-Bench spans multi-choice QA, information extraction, link prediction, and long-form QA in English and Chinese; BioMol-MQA extends the setting to multimodal polypharmacy reasoning over text, knowledge graphs, and SMILES (Verma et al., 8 Jul 2025, Zhu, 23 Jan 2026, Ji et al., 31 May 2025, Sengupta et al., 6 Jun 2025).

A common misconception is that biomedical QA is primarily a generation problem. The recent literature instead treats it as a coupled retrieval-and-generation problem in which retrieval coverage, reranking fidelity, evidence filtering, and post hoc verification materially affect final answer quality. This is made explicit in systems that separate dense retrieval, reranking, snippet vetting, and generation into distinct modules rather than a monolithic LLM call (Verma et al., 8 Jul 2025, Dong et al., 30 Apr 2025).

2. Canonical system architecture

Most RAG-BioQA systems implement a two-stage or multi-stage pipeline. In “Beyond Retrieval,” incoming queries are embedded and issued against a dense vector index built over approximately 34 million PubMed abstracts; the top-$K$ candidates, with $K=1{,}000$ as an example, are reranked and reduced to the top 10 documents, whose top snippets are concatenated into a passage block for generation (Verma et al., 8 Jul 2025). The long-form “RAG-BioQA” system follows a similar pattern but over a different knowledge base: BioBERT encodes the input question and a database of PubMedQA-derived QA pairs, FAISS performs initial nearest-neighbor retrieval with $k=16$, and rerankers select $n=4$ contexts before a fine-tuned T5 synthesizes the answer (Panchumarthi et al., 2 Oct 2025).

BioRAG generalizes this architecture into an iterative loop. It parses roughly 37 million PubMed XML records, filters out 14 million low-quality entries, retains 22,371,343 high-quality abstracts, segments them into passages of at most 512 tokens, indexes embeddings, and then repeatedly performs tool selection, query preprocessing, retrieval, and self-evaluation until the retrieved context is judged sufficient or 15 iterations are reached (Wang et al., 2024). The retriever is not restricted to a local vector database: the system can choose internal PubMed, external biology hubs such as Gene, dbSNP, Genome, and Protein, or general search engines including Google, Bing, arXiv, Wikimedia, and Crossref (Wang et al., 2024).

Discuss-RAG inserts explicit agentic modules around retrieval. Its pipeline contains multi-turn brainstorming with a summarizer agent and recruited experts, a retrieval module, a post-retrieval decision agent, and a generation module. The summarizer produces a refined summary $T^j$, a verifier distills the final discussion into context $D$, retrieval ranks snippets against $Q\!\parallel\!D$, and a decision agent accepts or rejects each retrieved snippet before answer generation (Dong et al., 30 Apr 2025).

A concise view of representative architectures is given below.

System	Indexed source	Retrieval pattern
BioRAG	22,371,343 filtered PubMed abstracts	Iterative multi-tool retrieval with self-evaluation
“Beyond Retrieval”	$\sim 34$ M PubMed abstracts	Dense retrieval, then cross-encoder and GPT reranking
“RAG-BioQA”	$\sim 181$ K PubMedQA-derived QA pairs	BioBERT + FAISS + optional reranking
Discuss-RAG	“medical textbooks” corpus	Retrieval conditioned on agent-produced distilled summary

These architectures differ in corpus choice and control flow, but they share the same operational premise: answer generation is conditioned on explicitly retrieved biomedical evidence rather than on parametric memory alone.

3. Retrieval, reranking, and reasoning strategies

Dense retrieval remains the dominant first stage. In “Beyond Retrieval,” a bi-encoder, bge-large-en, independently encodes queries and documents into 1024-dimensional vectors, with initial relevance computed by cosine similarity,

$\mathrm{score}_0(q,d)=\frac{q\cdot d}{\|q\|\|d\|}.$

The embeddings are stored in Qdrant, and dense retrieval alone already improves recall relative to a PubMed API baseline: recall@10 is reported as 0.23 versus 0.10 (Verma et al., 8 Jul 2025).

Reranking is often the decisive stage. “Beyond Retrieval” fine-tunes a transformer cross-encoder on BioASQ question–gold-document pairs using binary cross-entropy, then applies GPT-4o as a second reranker over the cross-encoder winners. Its final ensemble score is a weighted sum,

$K=1{,}000$0

and grid search on validation found $K=1{,}000$1 and $K=1{,}000$2, yielding MAP@10 $K=1{,}000$3 on held-out data. The same study reports that no reranking yields MAP@10 $K=1{,}000$4, while a one-stage cross-encoder gives MAP@10 $K=1{,}000$5; an alternative “nomination” strategy produced smaller gains (Verma et al., 8 Jul 2025).

Other systems pursue retrieval improvement through reasoning or structured priors rather than only reranking. Discuss-RAG uses a multi-agent discussion to refine the retrieval query and a decision-making agent to vet snippets after retrieval. On four datasets, it reports accuracy gains over MedRAG of $K=1{,}000$6 on MMLU-Med, $K=1{,}000$7 on MedQA-US, $K=1{,}000$8 on BioASQ, and $K=1{,}000$9 on PubMedQA, all statistically significant under a paired bootstrap test with $k=16$0 (Dong et al., 30 Apr 2025). BioRAG introduces MeSH-hierarchy augmentation. After a MeSH classifier predicts top-$k=16$1 tags, passages are filtered by MeSH overlap and rescored with a hierarchy-aware term,

$k=16$2

with typical weights $k=16$3 and $k=16$4. Its ablations show approximately 5-point loss without MeSH filtering, approximately 6-point loss without query rewrite, and up to 20-point loss on multi-hop tasks without self-evaluation (Wang et al., 2024).

Hybrid retrieval also remains important. MedBioRAG linearly fuses semantic and BM25 scores,

$k=16$5

with a typical $k=16$6, and reports that semantic retrieval improves NDCG@10 and MRR@10 over lexical retrieval on NFCorpus and TREC-COVID, while fusion yields slight further gains over pure semantic (Kim, 10 Dec 2025). By contrast, the long-form “RAG-BioQA” study reports that none of BM25, ColBERT, or MonoT5 outperform simple FAISS retrieval with BioBERT embeddings on PubMedQA (Panchumarthi et al., 2 Oct 2025). This suggests that the effectiveness of a reranking strategy depends strongly on the corpus representation and downstream task format.

For explicitly multi-hop biomedical QA, DeepRAG adds hierarchical decomposition and process-level supervision. On MedHopQA, it reports Exact Match $k=16$7 and Concept Accuracy $k=16$8, compared with $k=16$9 and $n=4$0 for vanilla RAG-Gym, and its ablations attribute losses to removing hierarchical reasoning, process supervision, or concept-level rewards (Ji et al., 31 May 2025).

4. Generation regimes

Generation modules in RAG-BioQA systems are typically instruction-tuned LLMs or parameter-efficiently adapted encoder-decoder models conditioned on retrieved evidence. In “Beyond Retrieval,” the prompt is assembled by concatenating top snippets into a “Passage” block, followed by the question and an output-format instruction such as “yes/no,” “ranked list of entities,” or “Write a short summary.” Few-shot prompting uses $n=4$1 or $n=4$2 examples, three prompt styles vary whether exact answers are hinted for ideal answers, and the model produces exact or ideal answers in a single turn (Verma et al., 8 Jul 2025).

The long-form “RAG-BioQA” framework is optimized for evidence-based paragraph generation rather than leaderboard-oriented exact answers. It formats the top $n=4$3 retrieved QA pairs as [Q1] [A1] [Q2] [A2] … [Q4] [A4] Question: [Query] Answer:, and feeds the result to FLAN-T5-base with LoRA. The reported LoRA configuration is rank $n=4$4, $n=4$5, and dropout $n=4$6; only about $n=4$7 of total parameters are updated. Training uses standard cross-entropy over target tokens, and decoding uses beam search with beam size 4 plus length normalization (Panchumarthi et al., 2 Oct 2025).

MedBioRAG uses GPT-4o fine-tuned on biomedical QA pairs, with the input defined as the concatenation of a system prompt, the query, and top-$n=4$8 retrieved contexts. The output may be a single letter for multiple-choice, “yes/no,” or a long-form explanation. Its reported fine-tuning details include 1–3 epochs, task-dependent batch sizes, top-$n=4$9 sampling in the $T^j$0–$T^j$1 range, low temperature in the $T^j$2–$T^j$3 range, and early stopping on a development set (Kim, 10 Dec 2025).

BioRAG retains a more classical RAG prompt but augments it with tool-manual instructions and one or two demonstration QA pairs when available. After self-evaluation returns “YES,” retrieved snippets are concatenated in descending retrieval-score order and passed to Llama3-70B with a prompt requesting a concise, accurate answer (Wang et al., 2024). Discuss-RAG conditions answer generation on the accepted snippet set $T^j$4, after the decision agent has filtered noisy or irrelevant evidence (Dong et al., 30 Apr 2025).

Across these systems, generation is not treated as unconstrained free-text synthesis. Output format, few-shot exemplars, beam or low-temperature decoding, and explicit instructions to abstain or follow evidence are all used to stabilize grounded biomedical answers.

5. Benchmarks and reported performance

Empirical evaluation of RAG-BioQA spans retrieval metrics, exact-answer metrics, and long-form NLG metrics. BioASQ remains the most visible benchmark for end-to-end biomedical QA, but PubMedQA, MedHopQA, GeneTuring, MRAG-Bench, and specialized datasets such as BioMol-MQA and RAGPPI broaden the space of evaluation (Verma et al., 8 Jul 2025, Zhu, 23 Jan 2026, Jeon et al., 28 May 2025).

Representative reported results are summarized below.

System	Setting	Reported result
“Beyond Retrieval”	BioASQ 2025 Task13b	Official retrieval MAP@10 $T^j$5, rank $T^j$6; factoid MRR $T^j$7, rank $T^j$8 (Verma et al., 8 Jul 2025)
Discuss-RAG	Four medical QA benchmarks	BioASQ $T^j$9; PubMedQA $D$0 (Dong et al., 30 Apr 2025)
BioRAG	Biological and medical QA	MedMCQA $D$1, Medical Genetics $D$2, College Biology $D$3, College Medicine $D$4 (Wang et al., 2024)
“RAG-BioQA”	PubMedQA long-form QA	Finetuned T5 + FAISS: BLEU-1 $D$5, ROUGE-1 $D$6, BERTScore $D$7, METEOR $D$8 (Panchumarthi et al., 2 Oct 2025)
MedBioRAG	Retrieval + QA benchmarks	MedQA $D$9; PubMedQA $Q\!\parallel\!D$0; BioASQ $Q\!\parallel\!D$1 (Kim, 10 Dec 2025)

The BioASQ 2025 system in “Beyond Retrieval” is especially illustrative because it separates retrieval from answer generation. On internal testing, the weighted reranking ensemble reaches MAP@10 $Q\!\parallel\!D$2; on the official leaderboard, retrieval MAP@10 is $Q\!\parallel\!D$3, while answer generation achieves macro-F1 $Q\!\parallel\!D$4 for yes/no questions, MRR $Q\!\parallel\!D$5 for factoid questions, mean-F1 $Q\!\parallel\!D$6 for list questions, and ROUGE-SU4 F1 $Q\!\parallel\!D$7 for ideal answers (Verma et al., 8 Jul 2025). This combination shows that end-to-end QA success can coexist with relatively modest official retrieval scores.

BioRAG emphasizes breadth across task types. It reports the highest accuracy in its table for MedMCQA and College Biology, ties the best result on Medical Genetics and College Medicine, and substantially improves several GeneTuring specialist tasks, including Gene alias $Q\!\parallel\!D$8, Gene location $Q\!\parallel\!D$9, and Gene–disease association $\sim 34$0 (Wang et al., 2024). The paper attributes these outcomes to a tailor-made biomedical embedding model, MeSH-hierarchy augmentation, iterative multi-tool search, and self-evaluation (Wang et al., 2024).

For long-form generation, the evidence is mixed but favorable to retrieval grounding. The long-form “RAG-BioQA” study reports that fine-tuning T5 on biomedical QA with FAISS retrieval improves BLEU-1 by $\sim 34$1 and ROUGE-1 by $\sim 34$2 over the unfine-tuned baseline, and that performance peaks at $\sim 34$3 final contexts (Panchumarthi et al., 2 Oct 2025). MedBioRAG reports improvements not only in close-ended accuracy but also in long-form metrics such as ROUGE, BLEU, BERTScore, and BLEURT across LiveQA, MedicationQA, PubMedQA, and BioASQ (Kim, 10 Dec 2025).

At the benchmark level, MRAG shows that RAG improves LLM reliability across medical tasks, that performance is influenced by retrieval approach, model size, and prompting strategy, and that long-form answers may become slightly less readable even as usefulness and reasoning quality improve (Zhu, 23 Jan 2026). This suggests that “better” biomedical RAG cannot be reduced to a single scalar metric.

6. Evaluation science, limitations, and future directions

Evaluation has become a major subtopic within RAG-BioQA because lexical overlap metrics do not fully capture groundedness, correctness, or completeness. CCRS introduces five zero-shot LLM-judged metrics—Contextual Coherence, Question Relevance, Information Density, Answer Correctness, and Information Recall—using Meta-Llama-3-70B-Instruct as a judge on BioASQ. In that setting, QR has discriminative power $\sim 34$4, IR $\sim 34$5, AC $\sim 34$6, and CC and ID $\sim 34$7; AC has a very low absolute mean near $\sim 34$8, and no system reaches perfect factual correctness under the strict $\sim 34$9 exact-match regime (Muhamed, 25 Jun 2025). Compared to RAGChecker, CCRS is reported as approximately $\sim 181$0 faster while offering comparable or superior discriminative power for key aspects such as recall and faithfulness (Muhamed, 25 Jun 2025).

Claim-level verification goes further. MedRAGChecker decomposes a generated biomedical answer into atomic claims, verifies each claim by evidence-grounded NLI over retrieved passages and by consistency with DRKG, then aggregates these decisions into diagnostics such as Faithfulness, Hallucination rate, under-evidence, and Safety-critical error rate. Its ensemble NLI checker reaches $\sim 181$1 overall accuracy with per-class F1-Contradict approximately $\sim 181$2, and KG fusion improves detection of unsupported or contradicted safety-critical claims from human agreement $\sim 181$3/Macro-F1 $\sim 181$4 to $\sim 181$5/$\sim 181$6 (Ji et al., 10 Jan 2026). A plausible implication is that answer-level scores can mask clinically important local failures.

The limitations documented across RAG-BioQA systems are recurring. “Beyond Retrieval” identifies the computational cost of GPT reranking and the sensitivity of ROUGE to surface-level overlap, which penalizes valid paraphrases (Verma et al., 8 Jul 2025). Discuss-RAG requires approximately 8–10 LLM prompts per query and incurs a $\sim 181$7–$\sim 181$8 latency increase versus vanilla RAG (Dong et al., 30 Apr 2025). BioRAG is limited by abstract-only local storage, MeSH classifier errors, and a maximum of 15 self-evaluation iterations that may time out on complex multi-hop questions (Wang et al., 2024). The long-form “RAG-BioQA” system restricts retrieval to QA pairs rather than full articles, and explicitly identifies conflicting evidence and deeper reasoning as open challenges (Panchumarthi et al., 2 Oct 2025). In BioMol-MQA, multimodal retrieval is the bottleneck: BM25 soft Hit@10 is approximately $\sim 181$9, hybrid soft Hit@10 is approximately $\mathrm{score}_0(q,d)=\frac{q\cdot d}{\|q\|\|d\|}.$0, and GNN-based graph retrievers fail to converge to useful embeddings on the small graph (Sengupta et al., 6 Jun 2025).

Future directions in the literature are correspondingly diverse. “Beyond Retrieval” proposes query reformulation via LLMs, more aggressive snippet filtering, larger retrieval pools, and refined prompt engineering (Verma et al., 8 Jul 2025). Discuss-RAG proposes peer-to-peer agent interactions, fine-tuning a lightweight binary verifier, and incorporation of structured knowledge bases such as UMLS (Dong et al., 30 Apr 2025). BioRAG leaves extension to other ontologies such as GO and UMLS as future work (Wang et al., 2024). Multimodal and workflow-grounded systems, including BioMol-MQA and 2D-ProteinRAG, point toward RAG-BioQA settings in which text retrieval is only one component among knowledge graphs, molecular structure, and expert biological workflows (Sengupta et al., 6 Jun 2025, Ding et al., 17 May 2026).

Taken together, the recent literature defines RAG-BioQA not as a single architecture but as a research program: dense or hybrid retrieval over biomedical corpora, increasingly sophisticated reranking and query-refinement strategies, task-specific answer generation, and a growing emphasis on grounded evaluation at both answer and claim level. The cumulative evidence suggests that retrieval quality, evidence filtering, and verification are central determinants of biomedical QA reliability rather than auxiliary engineering details.